Perelman Ups Stake in Sci Games

Scientific Games Corporation Chairman Ronald Perlman (l.) has increased his own stake in the company, buying 110,000 shares to increase his stake to 39 percent. The company has also sued one its largest shareholders to force it to reveal its connection to a Russian company active in illegal gambling.

Perelman Ups Stake in Sci Games

Ronald Perelman, the 76-year-old chairman of Scientific Games Corporation, has increased his stake in the company, spending $2.17 million go buy 110,000 shares at $19.73 per share to increase his ownership to 39.5 percent.

The acquisition follows Perelman’s buy last December of 1.5 million shares in the company.

Wall Street acted favorably to the news, with SGMS shares rising 5.16 percent to close at $20.78. This reversed a 4.45 percent dip following news the company is suing its third-largest shareholder, which may result in a forced redemption of 8.6 million shares owned by Hong Kong-based Sylebra.

SunTrust Bank gaming analyst Barry Jonas tied the purchase to the Sylebra case.

“Mr. Perelman has consistently added to his Scientific Games equity position when there’s been some sort of dislocation in the stock price – including (the) recent noise around Sylebra,” Jonas said, according to CDC Gaming Reports. “We think this points to Mr. Perelman’s current view on valuation and his longer-term conviction in the business.”

Meanwhile, Scientific Games has filed suit in Las Vegas to force disclosure of information from its third-largest shareholder, Hong Kong-based Sylebra Holdings.

The suit comes after repeated requests for information and disclosure documents from Sylebra, which owns a 9.34 percent stake in the supplier, to confirm the Hong Kong company’s suitability for licensing in the U.S.

The lawsuit claims Sylebra owns a large stake in a Russian company with alleged ties to illegal gambling, money laundering and support for terrorist organizations. The company says it has repeatedly asked the company for information “consistent with its ongoing obligation to inform regulators about matters relevant to suitability.”

Under Scientific Games’ corporate bylaws, the failure of Sylebra to comply with these requests could lead the company to declare it a “disqualified holder,” forcing redemption or sale of Sylebra’s 8.6 million shares in the company.

“Sylebra has manipulated the regulatory system by strategically timing the disclosure of information that it is willing to part with while utilizing procedural mechanisms to prevent any order requiring it to turn over the information that actually matters,” Scientific Games wrote in the lawsuit.

“This sustained pattern of obfuscation, procedural maneuvering and outright stonewalling—both in response to requests and the reasonable requests of governing regulators—raises serious questions about just what Sylebra might be trying to hide. These concerns have only increased given recent changes in ownership and management with respect to Sylebra

In an exclusive statement to CDC Gaming Reports, Susan Cartwright, SG’s vice president of corporate communications, said Sylebra has refused to supply basic information on its investors for more than two years.

“Scientific Games has now filed a lawsuit against Sylebra in Nevada state court asking for a ruling that Sylebra be required to provide us with the information we need to maintain the integrity and transparency our regulators expect and require of us,” Cartwright said.

“Scientific Games takes very seriously our obligation to maintain the highest standard of integrity and transparency with our regulators in Nevada, across the United States and around the world. As part of these efforts, we must be assured of the suitability of our major investors.”

**GGBNews.com is part of the Clarion Events Group of companies (Clarion). We take your privacy seriously. By registering for this newsletter we wish to use your information on the basis of our legitimate interests to keep in contact with you about other relevant events, products and services which may be of interest to you. We will only ever use the information we collect or receive about you in accordance with our Privacy Policy. You may manage your preferences or unsubscribe at any time using the link in our emails.